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Abstract
Existingmethods forthepredictionofimmunologicallyactiveT-cell epitopesarebasedontheaminoacidsequenceorstruc-
ture of pathogen proteins. Additional information regarding the locations of epitopes may be acquired by considering the
evolutionof viruses inhosts with differentimmune backgrounds. In particular,immune-dependentevolutionarypatternsat
siteswithin or nearT-cell epitopescan be used to enhance epitopeidentiﬁcation.We have developeda mutation–selection
modelofT-cellepitopeevolutionthatallowsthehumanleukocyteantigen(HLA)genotypeofthehosttoinﬂuencetheevolu-
tionaryprocess.This isoneoftheﬁrstexamplesoftheincorporationofenvironmentalparametersintoaphylogeneticmodel
and has many other potentialapplicationswhere the selection pressures exerted on an organism can be related directly to
environmentalfactors.WecombinethisnovelevolutionarymodelwithahiddenMarkovmodeltoidentifycontiguousamino
acid positionsthat appearto evolve under immune pressure in the presence of speciﬁc host immune allelesand that there-
fore represent potentialepitopes.This phylogenetichidden Markov model provides a rigorous probabilisticframework that
can be combined with sequence orstructural informationto improve epitopeprediction.As a demonstration,we applythe
model to a data setof HIV-1 protein-codingsequences andhost HLAgenotypes.
Keywords: epitopes,immune-mediatedevolution,phylogenetichidden Markov model.
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Introduction
An effectivecellularimmune responsedepends onthe pre-
sentation and recognition of foreign peptides called epi-
topes.Antigensfromendogenouspathogens,suchasavirus,
are degraded by the proteosome within the cytoplasmand
transportedtotheendoplasmicreticulum(ER)bythetrans-
porter associated with processing. In the lumen of the ER,
the peptide fragments undergo N-terminal trimming be-
fore attaching to human leukocyte antigen (HLA) class I
molecules for delivery to the cell surface and presenta-
tion to cytotoxic T lymphocytes (CTLs). The subsequent
bindingofthe epitope/HLAclassI complextothe T-cell re-
ceptorand CD8 coreceptor on a CTL induces clonalexpan-
sionandthereleaseofcytotoxinsthatlysethevirus-infected
cell (Vyas et al. 2008). Mutations of amino acid residues in
or around epitopes may inhibit any of these stages in the
antigenprocessingpathway, enablingviral escape from the
immune response. This is particularly evident in rapidly
evolvingviruses,suchastheHIVthatundergoeserror-prone
reverse transcriptionbefore integrationas a provirus in the
host’s DNA.
The genes encoding HLA molecules are highly polymor-
phic with distinct alleles having different peptide-binding
domains. HLA class I molecules are capable of presenting
peptide sequences of 8–11 amino acids with different
HLA alleles having distinct peptide-binding preferences.
The antigenic peptides that are ultimately presented to
CTLs therefore differ between individuals with different
sets of HLA alleles. Consequently, viral escape from CTL
recognition will depend on the HLA genotype of the host
and is thus said to be “HLA restricted.” Individuals express-
inga common HLA allelewillhave the potentialto present
acommonsetofepitopesandthustoharborsimilarescape
variants of the virus. Indeed, several studies have reported
robust correlationsbetween polymorphisms within or near
HIV epitopes and the HLA genotype of the host (Brumme
et al. 2008; Carlson and Brumme 2008; Navis et al. 2008;
Peters et al. 2008; Kawashima et al. 2009; Rousseau et al.
2008). These studieshighlight theimportantrole of thecel-
lular immune response in driving HIV evolution at sites in
and around HLA class I epitopes, resulting in adaptation
of the virus to HLA alleles both at the level of individual-
infectedhosts andat the populationlevel.
Accurate prediction of CTL epitopes is a key goal in
immunoinformatics (Yu et al. 2002; Flower 2003; Larsen
et al. 2005). Common approaches to this problem include
motif-based methods (Schuler et al. 2007), structure-based
methods (Rognan et al. 1999; Brusicet al. 2004), and
machine-learningalgorithms(Nielsenetal.2003; Zhaoetal.
2003; Yanover and Hertz 2005; Heckerman et al. 2006).
However, none of the tools proposed thus far consider
immune-mediated evolution as a distinguishing feature of
epitopes.Here, we develop a mutation–selectionmodel of
viral escape from host CTL responses, which is applicable
when viral-codingsequence data as well as host HLA geno-
typedataareavailable.ForanalignmentofHIV-1sequences
ofthesamesubtype,we assumethat thereisa singleamino
acid at each site, which is ﬁttest in the absence of a CTL
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response targeting the site. We refer to this residue as the
wild-type amino acid and approximate it with the most
common amino acid observed at a site in the alignment.
Versions of this assumption are commonly applied to dis-
tinguish immune escape and reversion mutations in HIV-
1 (see, e.g., Goonetilleke et al. 2009). In the presence of an
immune response targeting a speciﬁc site, selective pres-
sure for immune escape can cause a reduction in the fre-
quency of the wild-type amino acid. When a site is known
to be within a CTL epitope bound by a speciﬁc HLA al-
lele, we ﬁnd that allowing the frequency of the wild-type
amino acid to depend on whether or not the allele is ex-
pressed in the host often provides a much better descrip-
tion of the data. When it is not known whether a site is
within an epitope for a particular HLA allele, comparison
of the ﬁt of a model that allows the wild-type amino acid
frequency to dependon the presence of the allele (the epi-
topemodel)totheﬁtofamodelthatignoresHLAgenotype
(thenonepitopemodel)canprovideevidencethatthesiteis
withinorclosetoanepitope.Acontiguoussetofsitesfavor-
ingtheepitopemodelprovidestrongerevidenceforanepi-
tope. We show that this evidence can be combined using a
phylogenetichiddenMarkov model(phylo-HMM) tomake
probabilisticepitopepredictionsbased on sequence evolu-
tion.Evolutionaryinformationprovides a meansof epitope
prediction, which is orthogonal to existing sequence- and
structure-based methods. We demonstrate how this infor-
mation can be integrated with other prediction methods
within the phylo-HMM framework, takinga method based
on anchorresidue motifsas anexample.
Materials and Methods
Data
We analyzed a multiple alignment of 506 HIV-1 subtype
C Gag p17 and p24 sequences from a Durban, South
Africacohort,contributedtotheLosAlamosHIVMolecular
Immunology Database by Rousseau et al. (2008). The se-
quences and HLA genotypes of the subjects were deter-
mined as described in Rousseau et al. (2008). The data
utilizedin this study correspond to HXB2 Gag positions1–
358, excluding 16 amino acid sites at the end of p17 (posi-
tions 112–127) that appeared to be misaligned (most sites
containedmore than 90% gaps). Two HIV-1 subtype A and
subtype B sequences as well as an intersubtype recombi-
nant were removed from the original data set. The align-
ment was screened for intrasubtype recombination with
GARD (Kosakovsky Pond et al. 2006), but we were un-
able to detect departures from the star phylogeny within
estimated recombination breakpoints due to the large
number of taxa relative to the number of codon sites
between breakpoints. Consequently, we do not account
for intrasubtype recombination in our analyses, although
differentphylogeniesacrossthealignmentcouldbeaccom-
modated straightforwardly in principle. HLA-binding mo-
tifs and lists of optimally deﬁned epitopes were obtained
fromthe Los Alamos HIV MolecularImmunology Database
(http://www.hiv.lanl.gov/content/immunology).
Model of ImmuneEscape
We take account of immune-mediated selection pressure
bydevelopingacodonsubstitutionmodelwithsite-speciﬁc
equilibrium frequencies that reﬂect the dependence of the
wild-type amino acid at a site on the HLA genotype of the
host. Our model is based on that of Halpern and Bruno
(1998)inwhichdifferencesintheﬁtnessofcodonsaremod-
eledinterms ofsite-speciﬁccodon equilibriumfrequencies.
In this model, the instantaneous rate of substitution from
codon I to codon J, where we require that I andJ are both
sensecodons, is deﬁnedasfollows:
qIJ =
µk
ij ln
 
νJµk
ji
νIµ
k
ij
 
1 −
νIµk
ij
νJµ
k
ji
,( 1 )
where νJ is the equilibrium frequency of codon J at a par-
ticular site in the alignment, µk
ij is the mutation rate from
nucleotidei to nucleotide j in the kth codon position,and
ln{(νJµk
ji)/(νIµk
ij)}/{1−(νIµk
ij)/(νJµk
ji)}isproportional
to the ﬁxation probability of the mutation (Halpern and
Bruno1998). In our case,wewishtohavethisﬁxationprob-
abilitydependon the HLA genotypeof the infectedhost at
agivenpointontheviralphylogenywheneverthemutation
involves the replacement of a wild-type amino acid with
a non–wild type residue (escape mutation) or vice versa
(reversion mutation). In order to achieve this, we param-
eterize the site-speciﬁc codon equilibrium frequencies in
termsoftheequilibriumfrequencyofthewild-typeresidue,
γ,atasiteandd eﬁne
νJ =
⎧
⎨
⎩
γπJ 
X∈W πX if J ∈ W,
(1−γ)πJ
1−

X∈W πX if J / ∈ W,
(2)
where W represents the set of codons that encode the
wild-type amino acid and πJ is the equilibrium frequency
of codon J estimated empirically from the entire align-
ment as described in Kosakovsky Pond and Muse (2005).
An increase in the equilibrium frequency of the wild-type
residue, γ, therefore translates into an increase in the
equilibrium frequencies, νJ∈W, of codons that encode the
wild-type residue. The factors involving the πJ parameters
ensurethattheeffectsofcodonusagebias,estimatedacross
the whole alignment, are retained in the model. To al-
low γ to depend on the HLA genotype of the host, we
set γ = p0γ0 + p1γ1 with p0 + p1 = 1, where
p0 (p1) denotes the probability that a speciﬁc HLA allele
is absent (present) in the host, and γ0 (γ1)r e p r e s e n t s
the equilibrium frequency of the wild-type residue given
that the HLA allele is absent (present). We make the
simplifying assumption that the presence (p1 = 1) or
absence (p0 = 1) of a speciﬁcHLA allele during the entire
periodrepresentedbyabranchonthephylogenyisdictated
by the HLA genotype of the host at the tip of that branch.
When it is unknown whether or not the HLA allele is ex-
pressed in the host at a vertex in the phylogeny, such as at
all ancestral nodes, we set p0 and p1 equal to the propor-
tion of HLA-genotyped individuals in the study for which
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theparticularHLA alleleisabsentandpresent,respectively.
We also constrain γ0  γ1 because HLA-mediated selec-
tionpressureisexpectedtoincreasethefrequencyofescape
variantsoverwild-type aminoacids.
We parameterize the mutation rate µk
ij according to
the MG94×HKY85 Dual GDD 3×3 model of Kosakovsky
Pond and Muse (2005) and use an F3×4e s t i m a t o rf o rπJ.
Substituting these parameters into equation (1) yields the
following:
qIJ =
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎪ ⎩
πk
j α synonymous transversion,
κπk
j α synonymous transition,
πk
j β ×
ln(ζ)
1−ζ−1 transversion,I / ∈ W,J ∈ W,
πk
j β ×
ln(ζ
−1)
1−ζ transversion,I ∈ W,J / ∈ W,
πk
j β other nonsynonymous
transversion,
κπk
j β ×
ln(ζ)
1−ζ−1 transition,I / ∈ W, J ∈ W,
κπk
j β ×
ln(ζ
−1)
1−ζ transition,I ∈ W, J / ∈ W,
κπk
j β other nonsynonymous
transition,
0 >1 nucleotidedifference,
(3)
where πk
j denotes the equilibrium frequency of target
nucleotide j in codon position k, κ is the transi-
tion/transversion rate ratio, α is the synonymous sub-
stitution rate, β is the nonsynonymous substitution rate,
and ζ = {γ/(1 − γ)}{(1 −
 
X∈W πX)/
 
X∈W πX}.
Notice that the factors involving γ only appear in the
instantaneous rate matrix for substitutions that result in
the replacement of a wild-type residue with a non–wild
type residue or vice versa. Consequently, the selective
inﬂuence of the host’s HLA genotype is limited to these
substitutionsonlyas desired.
Equation (3) deﬁnes a time-reversible substitution pro-
cessforeachbranchinthephylogeny.However,theequilib-
rium frequencies, and hence the instantaneousrate matrix
describingthis model, will differfrom branchto branch de-
pendingonwhetheraspeciﬁedHLAalleleispresent,absent,
or unknown along that branch. Consequently, the substi-
tution process is not time reversible when considered over
t h ee n t i r et r e ea n dt h el o c a t i o no ft h er o o tn o d ea n dt h e
initial codon frequencies must therefore be speciﬁed. The
problemofidentifyingthe root node is greatlysimpliﬁedin
our case ifwe assume that the initialcodon frequenciesare
givenbyequation(2)withanindeterminateHLAgenotype.
Because theHLA genotypesofdonors are alwaysunknown,
the subprocess alongallinteriorbranches is time reversible
and hence any interior node other than the most recent
commonancestorsoftheleafnodesmaybeselectedtoroot
thetree.Indeed, therootofourHIV-1subtypeCphylogeny
did fall within this region of the tree when the two subtype
A and subtype B sequences in the original alignment were
usedas outgroups fortreeconstruction.
Let ψ ψ ψ  denote all the parameters except γ and γ0 in
the codon substitution process deﬁned by equation (3).
Because γ1 is deﬁned in terms of γ and γ0,i ti si g n o r e d
here. The site likelihood p(X |ψ ψ ψ ,γ,γ0) at column   in an
alignment X may then be computed for anyparameter val-
ues in {(γ,γ0) :0 γ  γ0  1} and nonnegative real-
valuedbranchlengthsalongaphylogenyusingFelsenstein’s
pruning algorithm (Felsenstein 1981). We adopt a random
effects approach with respect to the parameters γ and γ0
andintegratethem out ofthe sitelikelihoodto obtain
pE(X |ψ ψ ψ
 )
=
 
γ
 
γ0
p(X |ψ ψ ψ
 ,γ,γ0)p(γ0|γ,ξ ξ ξ0)p(γ|ξ ξ ξ) dγ0 dγ,( 4 )
where p(γ0|γ,ξ ξ ξ0) and p(γ|ξ ξ ξ) denote prior distributions
on γ0 and γ with hyperparameters ξ ξ ξ0 and ξ ξ ξ, respectively.
The subscript E in the likelihood pE(X |ψ ψ ψ ) refers to the
epitope state and is introduced here to highlight the fact
thatthissitelikelihoodwascomputedbyallowingtheequi-
librium frequency of the wild-type amino acid to depend
on the HLA genotype of the host, as would be expected in
epitoperegions of the viralgenome. In nonepitoperegions,
theabsenceofHLA-mediatedselectivepressureimpliesthat
γ = γ0 = γ1 and site likelihoods may therefore be com-
putedas
pN(X |ψ ψ ψ
 )=
 
γ
p(X |ψ ψ ψ
 ,γ)p(γ|ξ ξ ξ)dγ.( 5 )
This is equivalent to equation (4) with p(γ0|γ,ξ ξ ξ0)=1i f
γ0 = γ and p(γ0|γ,ξ ξ ξ0)=0 otherwise. A comparison of
pE(X |ψ ψ ψ ) andpN(X |ψ ψ ψ ) overa region of the viral genome
will reveal localizedsets of sites that evolve under immune
pressureandare thus indicativeof CTLepitopes.We traina
hidden Markov model withthe stateemissionprobabilities
given by equations (4) and (5) and hence are able to infer
theepitopeandnonepitopestatestakingaccountofallthe
informationavailableacross the alignment.
Phylogenetic Hidden Markov Model
A phylo-HMM is deﬁned as the four-tupleθ θ θ =( S,ψ ψ ψ, A, b)
consisting of a set of M hidden states S = {S1,...,SM}
with associated phylogenetic modelsψ ψ ψ = {ψ ψ ψy : y ∈ S},
a state transitionprobabilitymatrix A = {ayz} for y,z ∈ S
anda vectorof initialstate probabilitiesb =( bS1,...,bSM)
(Siepel and Haussler 2005). Here, all hidden states share
a common phylogenetic model and differ only in the
constraints imposed on the parameters γ and γ0 in
the computation of the state emission probabilities. This
continuous-time Markov stochastic process is deﬁned by
aninstantaneouscodonsubstitutionratematrix Q withen-
tries given by equation (3), codon equilibrium frequencies
given by equation (2) and a binary tree topology with a
corresponding set of branch lengths. The constraints on γ
andγ0 determine whether evolutionin a particularstateis
immune mediated or not.
Letφ φ φ =( φ1,...,φL) denote a paththrough the phylo-
HMM with φ  ∈ S for1     L in an alignmentX with L
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codon sites. The joint probabilityof the alignment and the
pathis
p(X,φ φ φ|θ θ θ)=bφ1pφ1(X1|ψ ψ ψ
 )
L  
 =2
aφ−1,φpφ(X |ψ ψ ψ
 ).
Theemissionprobabilitypφ(X |ψ ψ ψ )isgivenbyequation(4)
if φ  corresponds to the epitope state and equation (5) if
it corresponds to the nonepitope state. The likelihood of
the alignment p(X|θ θ θ)=
 
φ φ φ p(X,φ φ φ|θ θ θ) may be computed
with the forward algorithm, whereas the maximum likeli-
hood pathφ φ φML = argmaxφ φ φp(X,φ φ φ|θ θ θ) may be obtained via
Viterbidecoding.The forward–backwardalgorithmmaybe
used to obtain posteriorstateprobabilitiesp(φ  = y|X,θ θ θ)
forall  andy (Rabiner1989).
Two-State Epitope Model
WeﬁrstconsideramodelwithS = {E,N}whereE denotes
an epitope state and N denotes a nonepitope state. The
emissionprobabilitiesfortheepitopeandnonepitopestates
aregivenbyequations(4)and(5),respectively.Tocompute
these probabilities,we deﬁne p(γ|ξ ξ ξ) as a beta distribution
on [0,1] and p(γ0|γ,ξ ξ ξ0) as a beta distribution with sup-
port[γ,min(γ/ˆ p0,1)],w h e r eˆ p0 is an empiricalestimateof
the proportion of individuals who do not express the HLA
allele under consideration. The support of p(γ0|γ,ξ ξ ξ0) en-
sures that 0  γ1  γ  γ0  1. In order to allevi-
ate the computationalburden of numerical integration,we
utilizediscretizedversionsofthesedistributionsthatallows
the double integrationto be approximatedby summation.
For each γ ∈{ 0.05 + 0.15i : i = 1,...,5},w ec o m p u t e
thelikelihoodp(X |ψ ψ ψ ,γ,γ0)atsevenequallyspacedvalues
ofγ0 intheinterval[γ,min(γ/ˆ p0,1)]forthe epitopestate.
A betterapproximationto the integrationmay be attained
with a ﬁner discretization over the (γ,γ0) space, particu-
larly near the support boundaries when the beta densities
areconvex;however,ourexperiencesuggeststhattheincre-
mentalgaininpredictiveaccuracy isnotworththeincrease
in computational time needed to calculate the likelihood
functionfor the additional(γ,γ0) pairs at every site. Given
estimates of the hyperparameters ξ ξ ξ and ξ ξ ξ0,t h ed e n s i t yo f
each (γ,γ0) pair is computed and normalized to obtain
its joint probability. The probability pE(X |ψ ψ ψ ) of the epi-
tope stateemittingalignmentcolumn X  is then calculated
as the sum of the conditional probabilities p(X |ψ ψ ψ ,γ,γ0)
weighted by the joint probabilities of γ and γ0.T h ee m i s -
sionprobabilitypN(X |ψ ψ ψ )forthe nonepitopestateiscom-
puted analogouslywith respect to the discretized marginal
distributionon γ.This model is illustratedinﬁgure 1A.
Epitope Model with Duration
The two-state model ignores several known sequence and
structural features of epitopes. The requirement that an
epitope be between 8 and 11 amino acids in length in or-
der to bind to an HLA class I molecule is perhaps the sim-
plest constraint that is not considered in the two-state
model. We incorporate this restriction by deﬁninga phylo-
HMM with duration (phylo-HMMwD) on the state space
FIG.1 . (A) Two-state epitope model. (B) Phylo-HMMwD+M for
HLA-B*57. Modiﬁcations to the phylo-HMMwD are indicated with
dashed lines.
S = {E1,...,E11,N},w h e r eEi denotes the ith amino
acid in the epitope state for i = 1,...,11. The architec-
ture of this model is illustratedwith solid nodes and edges
in ﬁgure 1B. The phylo-HMMwD provides the foundation
for incorporating other spatial features relevant to epi-
tope prediction.In what follows,we show how to integrate
motif-basedpredictionwithsequenceevolutionwithinthis
framework.
Phylo-HMMwD Integrated with Motif-Based
Prediction
Motif-basedmethods ofepitopepredictionexploitthefact
that the binding afﬁnity of an antigenic peptide and HLA
molecule is critically dependent on a few anchor residues
in the peptide sequence. For example, ligands of HLA-B*57
molecules typically have the form X[ATS]XXXXXX[FW],
wheretheaminoacidsinsquarebracketsindicatedominant
anchorresiduesandXdenotesanindeterminateaminoacid
(Marsh et al. 2000). The region between the two anchors
is of variable length and affects the conformational struc-
ture of the bound peptide-HLA complex (Stewart-Jones
et al. 2005). We demonstrate how to extend our phylo-
HMMwD to incorporate motif-based epitope prediction
usingHLA-B*57 as an example.We include the anchormo-
tif in the model by replacing states E2 and E11 with anchor
states A1 and A2 in ﬁgure 1B. Because anchor motifs are
HLA speciﬁc, the architecture of the graphical model de-
scribing the sequence of hidden states will differ between
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HLA alleles. Epitope prediction may also be informed by
processing escape mutations that have been reported
in the N-terminal ﬂanking regions of some epitopes
(Draenert et al. 2004). We therefore introduce three op-
tional ﬂanking states F1, F2,a n dF3 prior to entry into the
ﬁrstepitopestateE1 inﬁgure 1B.Wewillrefertothismodel
asaphylo-HMMwD+M,wherethesufﬁx“+M”indicatesthe
combining of a phylo-HMMwD with motif-based epitope
prediction.
To take account of the anchor motifs, we deﬁne an in-
dicator variable 1 i(r  λ),o r1 i for short, which equals
oneiftheproportionrofobservedaminoacidscorrespond-
ing to anchor residue i at site   i sg r e a t e rt h a no re q u a lt o
ap r e d e ﬁ n e dt h r e s h o l dλ and zero otherwise. In the case of
HLA-B*57, for example, 1 1 indicates whether the propor-
tion of sequences with Ala, Thr, or Ser at site   exceeds λ.
The indicator variable 1 2 is similarly deﬁned with respect
to Phe and Trp. The probability of emitting column X  un-
der the ithanchor stateisthen
pAi(X |ψ ψ ψ
 )=
 
j∈{0,1}
pAi(X |1 i = j,ψ ψ ψ
 )pAi(1 i = j|ψ ψ ψ
 )
= pAi(X |1 i = 1,ψ ψ ψ
 )
because pAi(1 i = 0|ψ ψ ψ )=0a n dpAi(1 i = 1|ψ ψ ψ )=1.
Setting pAi(X |1 i = 1,ψ ψ ψ )=pE(X |1 i = 1,ψ ψ ψ ),w eo b -
tain
pAi(X |ψ ψ ψ
 )=
 
pE(X|ψ ψ ψ )
pE(1i=1|ψ ψ ψ ) if1 i = 1
0o t h e r w i s e ,
because pE(X |1 i = 0,ψ ψ ψ )=0w h e n1 i = 1a n dt h u s
pE(X |ψ ψ ψ )=pE(X |1 i = 1,ψ ψ ψ )pE(1 i = 1|ψ ψ ψ ).T h e
probability pE(X |ψ ψ ψ ) is given by equation (4) and we ap-
proximate pE(1 i = 1|ψ ψ ψ ) with the proportion of align-
ment sites at which 1 i = 1. Note that if λ = 0, 1 i = 1
at all sites and the anchor residues will not inform epitope
prediction.Largervaluesofλwillresultinanchorstateemis-
sion probabilities of zero at some sites and thereby restrict
epitopepredictionsto those regionswhere the anchormo-
tifs are observed in at least some of the aligned sequences.
Inouranalyses,wesetλ = 0.3andwillthereforenotdetect
epitopes when the anchor residues are only present in less
than30%ofsequences.Itisworthnotingthatatalmost90%
ofthesitesinouralignment,the mostcommon aminoacid
occurredatafrequencygreaterthan80%andourresultsare
consequentlyrobust to the choice of λ.
Implementation
Givenaninferredtopology(seebelow)andassumingF3×4
codonequilibriumfrequencies,allothermutationalparam-
eters in equation (3) and the branch lengths were esti-
matedbymaximum likelihoodinHyPhy (KosakovskyPond
etal.2005)underastandardMG94×HKY85DualGDD3×3
modelofcodonsubstitution(i.e.,withoutthefactorinvolv-
ingζ inequation(3)). Sitelikelihoodswere then computed
under the Halpern–Bruno model deﬁned by equation (3)
fordiscrete values ofγ andγ0 given the previouslyinferred
mutational parameters and branch lengths. The hyperpa-
rameters of the prior distributions on γ and γ0 and the
transition probabilities between hidden states were opti-
mizedwiththeBaum–Welchalgorithmimplementedinthe
R Language and Environment for Statistical Computing
(R Development Core Team 2009). The initial state prob-
abilitieswere constrainedsuch thatthe Viterbipathalways
beginsinthe nonepitopestate.The computercode is freely
availablefrom the correspondingauthor.
In order to determine the extent to which our results
depend on the inferred phylogeny, we estimated several
maximumlikelihoodtopologiesusingPhyML(Guindonand
Gascuel 2003) and GARLI (Zwickl 2006). Fifteen trees were
estimated with different starting topologies in PhyML by
specifying a general time reversible model of nucleotide
substitution with variable substitution rates modeled by a
four-category discrete gamma distribution with unit mean.
Branchswapswereachievedbysubtreepruningandregraft-
ing and nearest neighbor interchange. A further 20 trees
were inferred with GARLI under a GY94×HKY85 codon
substitutionmodel withnonsynonymousratesdrawn from
a three-category general discrete distribution. We trained
our phylo-HMMs using several of the highest scoring
topologies and did not ﬁnd any substantive differences in
our results. The phylogeny ultimately used here was re-
solvedinPhyML andhad the highest likelihoodscore com-
puted in HyPhy under the MG94×HKY85 Dual GDD 3×3
model of codon substitution.
Results
Weappliedourmodelstoamultiplealignmentof506HIV-1
subtypeC Gag p17andp24sequencesdescribed inMateri-
als and Methods. All amino acid positionsdiscussed below
correspondto those of the HXB2 referencestrain.
Predicted HLA-B*57-restricted epitopes
WebeginbyconsideringthespeciﬁccaseofHIV-1evolution
in the context of the HLA-B*57 allele for which immune-
mediated escape and compensatory mutations have been
extensivelydocumented. Twenty-six of the 502 HLA-typed
individuals in this study were HLA-B*57 positive (HLA-
B*57+). The majority(15/26) of theseindividualsexpressed
the HLA-B*5703 molecule as expected in African popula-
tions (Cao et al. 2004), whereas 7 expressed HLA-B*5702,
andthe remainder were typed at two-digit resolutiononly.
Molecular differences between HLA-B*57 alleles do not,
however, signiﬁcantly affect peptide-binding afﬁnity and
we therefore expect a considerable overlap in their bound
peptiderepertoires(Stewart-Jonesetal.2005), althoughdif-
ferentialT-cell receptorrecruitment may result insubtype-
speciﬁcescape(Yu et al.2007).
A comparison of the integrated site likelihoods of the
HLA-B*57-restricted epitopemodel andnonepitopemodel
ispresentedinﬁgure 2.For eachsiteinGag p17andp24,we
computedthe Bayes factor
B =
pE(X |ψ ψ ψ )
pN(X |ψ ψ ψ )
assuming ﬂat priors on γ and γ0 given γ and plotted
2ln(B), which is on the same scale as the likelihood ratio
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FIG.2 . Bayesfactorscomparing the HLA-B*57-restricted epitope model tothe nonepitope model at each sitein HIV-1 Gag p17 and p24. Shaded
regions indicate the degree of evidence in favor of the epitope model: white indicates negligible evidence, light gray indicates positive evidence,
intermediate gray indicates strong evidence, and dark gray indicates deﬁnitive evidence (Kass and Raftery 1995). Prominent escape mutations
known to be associated with the HLA-B*57 allele are annotated. Black dots indicate sites with a signiﬁcant (q < 0.2) association between host
HLA and HIV mutations as determined by the phylogenetically correctedmethod described in Bhattacharyaet al. (2007).
teststatistic(KassandRaftery1995). Theresultsofthetwo-
statephylo-HMM andphylo-HMMwD+M areillustratedin
ﬁgure3foraregionofthep24proteinknowntocontainim-
munodominant HLA-B*57-restricted epitopes. The results
for the entire Gag p17 and p24 region are given in supple-
mentary ﬁgures S1 andS2, SupplementaryMaterialonline.
Strong HLA-B*57-mediated selection pressure has been
describedinandaroundthree peptidesinthe Gagp24cap-
sidregion(Choperaetal.2008;Crawfordetal.2009),namely
ISW9 (147ISPRTLNAW155),TW10 (240TSTLQEQIAW249),and
KF11 (162KAFSPEVIPMF172) (anchor residues are under-
scored). Escape from ISW9 occurs ﬁrst during acute HIV-
1 subtype C infection in HLA-B*57+ African populations
(Crawford et al. 2009). The processing escape mutation
A146P is often observed in the N-terminal ﬂanking posi-
tionof thisepitopeandpreventsER aminopeptidaseI from
cleavinganN-extendedpeptidetoanoptimalsizeforbind-
ing to the HLA-B*57 molecule (Draenert et al. 2004). A fur-
ther escape substitution of Ile for Leu at site 147 has also
been described (Draenert et al. 2004; Peters et al. 2008).
Figure 2 shows strong evidence in support of the epitope
modelatposition146andpositiveevidenceatposition147.
Thetwo-statephylo-HMMcapturesbothescapemutations
with sharp peaks in the posterior probability of the epi-
tope state at sites 146 and 147 in ﬁgure 3. Viterbi decod-
ing of the phylo-HMMwD+M correctly predicts the ISW9
epitope.
Two escape sites at positions 242 and 247 within the
TW10 epitope are identiﬁed by large Bayes factors in
ﬁgure 2andhigh posteriorprobabilitiesin ﬁgure 3.T h ef o r -
mer position corresponds to the well-known T242N muta-
tionobservedinalmostallHLA-B*57+individuals(Brumme
et al. 2008), whereas a mutation from Ile to Val at the lat-
ter position appears to be speciﬁc to HLA-B*57+ individ-
uals infected with HIV-1 subtype C (Crawford et al. 2009).
The T242N mutation disrupts critical interactionswith the
host protein cyclophilin A (CypA) resulting in a 10-fold re-
duction in viral replicative capacity (Borghans et al. 2007).
This ﬁtness loss may be partiallyrestored by compensatory
substitutions,particularlyinornearthe CypA-bindingloop
upstream of the TW10 epitope (Brockman et al. 2007). In-
deed, ﬁgure 3 indicates some, albeit weaker, evidence in
favorofthe epitopestateatsitescorrespondingto the pre-
viously described H219Q and M228I/L compensatory mu-
tationswithin thisregion.
The KF11 epitope is immunodominant during chronic
infection (Leslie et al. 2005). Escape mutations have been
described at positions 163 and 165 within this epitope, al-
thoughtheirprevalencedependsonthe HIV-1subtypeand
the speciﬁc HLA-B*57 allele, with more frequent escape
FIG.3 . Posterior probabilities of the epitope state for HLA-B*57 in HIV-1 Gag p24 based on the two-state epitope model. Gray-shaded regions
indicate epitopes predicted by Viterbi decoding of the phylo-HMMwD+M with the posterior probability of each epitope given on the top right-
hand corner. Predicted anchors are shaded in dark grey and ﬂanking regions are shaded in light gray. Black dots indicate epitopes predicted by
Viterbidecoding ofthetwo-statemodel. Thebestdeﬁnedor“A-list”epitopes describedinYusimet al.(2009) areindicatedwithwhitetextagainst
a black background.
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observedincladeCsequencesinthecontextofHLA-B*5703
(Yu et al. 2007). It is therefore not surprising that our two-
state phylo-HMM predicts both these mutations. Indeed,
theBayesfactorstoofavortheepitopemodelattheseposi-
tions.AmutationfromAlatoGlyatposition163occursﬁrst
inHLA-B*57+ individualsandinhibitsintracellularprocess-
ing of the epitope precursor but compromises viral ﬁtness
substantially(Leslie et al. 2005). This ﬁtness cost is partially
restored by a compensatory substitution of Ser for Asn at
position165, which may explainthe lower Bayes factorand
posterior escape probabilityat this site relative to position
163.
Finally, a further B*57-restricted epitope QW9
(308QATQDVKNW316) has also been mapped to the
p24 capsid protein (Stewart-Jones et al. 2005). Two mu-
tations within this epitope, namely S310T and E312D,
have been described (Navis et al. 2007). However, these
mutations represent the most common variant of QW9 in
HIV-1 subtype C anddo not appearto be the result of CTL
escape (Currier et al. 2005). Correspondingly, we too do
not ﬁnd any evidence of escape at these or any other sites
withinthe QW9 epitope.
Epitope Predictions for Other HLAAlleles
We used our phylo-HMMs to predict epitopes for a fur-
ther31HLAallelesthatwereobservedatrelativelyhighfre-
quencies andfor which anchor motifs were availablein the
LosAlamosHIV MolecularImmunology Database.Foreach
HLA allele, the phylo-HMMwD+M was deﬁned to accom-
modate epitopes of 8 to 11 amino acids in length with an
N-terminalﬂankingregionof3aminoacids.Fullplotsofthe
epitopespredicted in HIV-1 Gag p17 and p24 are provided
as supplementary ﬁgures S1 and S2, Supplementary Mate-
rialonline,foralltheHLAmoleculesconsidered.Theanchor
motifsused foreach alleleare givenin supplementarytable
S1,SupplementaryMaterialonline.
Overall, Viterbi decoding revealed 81 and 65 epi-
topes across all HLA alleles in the phylo-HMMwD and
phylo-HMMwD+M, respectively, compared with 191
nonoverlappingepitopesidentiﬁedby simply countingthe
number of segments with appropriately spaced anchor
residues present in at least 30% of sequences (see sup-
plementary table S2, Supplementary Material online, for
details). The results clearly indicate that the number of
potential epitopes based solely on anchor motifs is much
larger than that predicted by either phylo-HMM consid-
ering evolutionary information. Indeed, the phylo-HMMs
limit the set of predictions to only those epitopes, which
exhibit HLA allele-dependent immune escape. We also
examined the proportion of predicted epitopes, which
overlap with known epitopes documented in Yusim et al.
(2009) for each of the three methods but did not ﬁnd
any notable differences (anchor motifs only, 0.33; phylo-
HMMwD, 0.26; and phylo-HMMwD+M, 0.37). However,
predicted epitopes that are unknown are not necessarily
false positives,and, in fact, these are more likelyto be valid
epitopes under the phylo-HMMwD+M where predictions
satisfyanchormotifsandexhibitimmune-mediatedescape
patterns. Moreover, we envisage that our model be com-
bined with additional sequence and structural information
so as to further reduce the number of false positives that
may occur.
Many well-known epitopes do not conform to the doc-
u m e n t e dH L A - b i n d i n gm o t i f sa n dw i l lb em i s s e db yt h e
phylo-HMMwD+M. For example, noneof the knownHLA-
B*5802-restricted epitopes in HIV-1 Gag p17 and p24 doc-
umented in Yusim et al. (2009) contain the anchor motif
X[ST]XXX[R]XX[F] suitable for binding to an HLA-B*5802
molecule (Marsh et al. 2000; Schuler et al. 2007). The
two-state epitope model and phylo-HMMwD are likely to
be more useful in such cases where there may be uncer-
tainty regarding the binding motif. For example, the pos-
terior probabilities of the two-state model for HLA-C*04
clearly indicate strong immune pressure within the known
HLA-C*04-restricted epitope QW9 (308QATQDVKNW316),
even though this epitope is undetected by the phylo-
HMMwD+M, which speciﬁes a Tyr, Phe, or Pro B-pocket
anchor residue and a Leu, Phe, or Met F-pocket anchor
residue.
Discussion
Pathogens, such as HIV-1, adapt to common immune
responses in host populations (Kawashima et al. 2009)
and to the immune repertoire of speciﬁc infected hosts
(Bhattacharya et al. 2007). This phenomenon has attracted
substantialinterestinthe HIV-1 ﬁeld,partlybecause itpro-
videsinsightsintothefuturetrajectoryofthepandemicbut
also because the interplay between the immune response
and the evolving virus is an essential component of HIV-
1 disease dynamics. In this work, we have developed the
ﬁrst mutation–selection model of CTL escape, incorporat-
ing host HLA information explicitly into the evolutionary
m o d e l .W ec a nt h e nm a k eu s eo fm o d e lc o m p a r i s o nt e c h -
niques to identify sites within the virus that are correlated
with host HLA alleles. Amino acid positions that support
the model of epitope evolution are consistent with viral
polymorphisms thathave beenreportedas associatedwith
the host HLA genotype. Because CTLs recognize linearepi-
topes,we canincorporatethismodel intoaphylo-HMM to
predict epitopes on the basis of patterns of evolution at
contiguous amino acid positions. Indeed, the possibility of
combining evidence from evolutionary models over con-
tiguous sites makes the problem of predicting linear epi-
topesa naturalapplicationofphylo-HMMs.
CurrentmethodsforpredictingT-cellepitopesarebased
on the characteristics of individual amino acid sequences
that affect peptide processing in the endogenous pathway
orbindingby HLA molecules. As described above, epitopes
arealsoassociatedwithcharacteristicpatternsof evolution
andwe demonstratehere that the phylo-HMM framework
allowsus tointegratethisevolutionaryevidenceintoanex-
isting sequence-based strategy to enhance epitope predic-
tion. In doing so, we shift the focus from the prediction of
epitopes in individual sequences to the prediction of epi-
topes that tend to occur in a set of viruses circulating in
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a host population for which HLA data are available. Our
approach is unlikely to identify all the potential epitopes
in a given sequence; rather, it is designed to identify epi-
topes that are associated with consistent patterns of im-
mune escape and reversion. This is the case for many
well-studiedandimportantepitopesinHIV-1.Epitopesthat
exhibit consistent patterns of immune escape and rever-
sion are signiﬁcant because they frequently correspond to
immune responses for which there are a limited number
of possible escape pathways and for which escape mu-
tations incur a ﬁtness cost, such that they tend to re-
vert upon transmission to a host lacking the required HLA
allele.
The evolutionary models are ﬁtted separately for each
HLA allele, followed by decoding of the phylo-HMM to
predict the corresponding epitopes. However, HLA alle-
les do not occur independently of one another. Instead,
it is possible for different HLA alleles to cooccur more of-
ten than would be expected by chance, either as a result
of linkage disequilibrium or populationstructure. To iden-
tify HLA alleles that cooccur, we carried out Bonferroni-
corrected Fisher’s exact tests (supplementary table S3,
Supplementary Material online) and subsequently exam-
ined the epitope predictions of the associated alleles to
see if we could identify false positives resulting from link-
age. In several cases, common peaks in the posterior
probabilities of the epitope state based on the two-state
epitope model are observed for HLA alleles, which exhibit
signiﬁcant linkage disequilibrium (see, e.g., the p17 region
in supplementary ﬁgure S1, Supplementary Material on-
line,forHLA-B*4201andHLA-C*1701).Undocumentedepi-
topes predicted by the phylo-HMMwD+M and presented
by such HLA molecules were screened and highlighted as
potentially spurious where appropriate. However, in most
cases, the speciﬁcation of HLA speciﬁc–binding motifs
in the phylo-HMMwD+M eliminates these potential false
positives.
The characteristic pattern of HLA-associated evolution
provides a basis for epitope prediction, which is orthogo-
naltothecharacteristicsofindividualsequences.Asaresult,
it is possible to combine this with any existing sequence-
orstructure-basedepitopepredictionstrategy.We demon-
strated this using the example of motif-based epitope
prediction. Because the sequence motifs associated with
HLA binding have a low-information content, an epitope
prediction method that considers motifs exclusively has a
very high false positive rate. Combining the phylo-HMM
with motif-based prediction, we were able to substantially
reducethenumberofpredictedepitopes.Wearguethatthe
resultingpredictionsarethemostrelevantbecausetheyare
associatedwitha shared patternof immune escapeand re-
version across different infections.The combination of the
phylo-HMM with motif-based prediction also provided a
fullyprobabilisticapproachtoepitopepredictionandiseas-
ily interpretable. For example, we can calculate the poste-
rior probabilityof an epitope at each amino acid site using
the forward–backward algorithm, which is accurate given
the explicit assumptions of the model. Consequently, we
present the phylo-HMM as a general epitope prediction
framework, which may be readily adaptedto combine evo-
lutionaryevidenceofanepitopewithanyotherepitopepre-
diction method.
Supplementary Material
Supplementary ﬁgures S1 and S2 and tables S1, S2,a n d
S3 are available at Molecular Biology and Evolution online
(http://www.mbe.oxfordjournals.org/).
Acknowledgments
TheauthorswishtothankSergeiL.KosakovskyPondforuse
of his LinuxclusterandassistancewithHyPhy.
References
BhattacharyaT, Daniels M, Heckerman D, et al. (20 co-authors). 2007.
Founder effectsintheassessmentofHIVpolymorphisms andHLA
allele associations.Science 315:1583–1586.
BorghansJAM,MølgaardA,BoerRJD,Kes ¸mirC.2007.HLAallelesasso-
ciatedwithslowprogressiontoAIDS trulyprefer topresent HIV-1
p24. PLoS One.2:e920.
BrockmanMA,SchneidewindA,LahaieM,etal.(14co-authors).2007.
Escape and compensation from early HLA-B57-mediated cyto-
toxic T-lymphocyte pressure on human immunodeﬁciency virus
type 1 Gag alter capsid interactions with cyclophilin A. J Virol.
81:12608–12618.
BrummeZL,BrummeCJ,CarlsonJ,etal.(21co-authors).2008.Marked
epitope- and allele-speciﬁc differences in rates of mutation in hu-
man immunodeﬁciency type 1 (HIV-1) Gag, Pol, and Nef cyto-
toxicT-lymphocyteepitopesinacute/earlyHIV-1infection.JVirol.
82:9216–9227.
Brusic V, Bajic VB, Petrovsky N. 2004. Computational methods for
prediction ofT-cellepitopes—aframework formodelling, testing,
and applications. Methods34:436–443.
Cao K, Moormann AM, Lyke KE, et al. (18 co-authors). 2004. Differen-
tiation between African populations is evidenced by the diversity
of alleles and haplotypes of HLA class I loci. Tissue Antigens. 63:
293–325.
Carlson JM, Brumme ZL. 2008. HIV evolution in response to HLA-
restricted CTL selection pressures: a population-based perspec-
tive. Microbes Infect. 10:455–461.
Chopera DR, Woodman Z, Mlisana K, et al. (12 co-authors).
2008. Transmission of HIV-1 CTL escape variants provides HLA-
mismatched recipients with a survival advantage. PLoS Pathog.
4:e1000033.
Crawford H, Lumm W, Leslie A, et al. (18 co-authors). 2009. Evolution
of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive
individuals and their transmission recipients. JE x pM e d . 206:
909–921.
Currier JR, Harris ME, Cox JH, McCutchan FE, Birx DL, Maayan S,
Ferrari G. 2005. Immunodominance andcross-reactivityofB5703-
restrictedCD8TlymphocytesfromHIVtype1subtypeC-infected
Ethiopians. AIDS Res Hum Retroviruses. 21:239–245.
Draenert R, Le Gall S, Pfafferott KJ, et al. (12 co-authors). 2004.
Immuneselectionforalteredantigenprocessingleadstocytotoxic
T lymphocyte escape in chronic HIV-1 infection. JE x pM e d . 199:
905–915.
Felsenstein J. 1981. Evolutionary trees from DNA sequences: a maxi-
mum likelihood approach. J Mol Evol. 17:368–376.
Flower DR. 2003. Towards in silico prediction of immunogenic epi-
topes.Trends Immunol. 24:667–674.
1219Lacerda et al. · doi:10.1093/molbev/msq008 MBE
Goonetilleke N, Liu MK, Salazar-Gonzalez JF, et al. (24 co-authors).
2009. The ﬁrst T cell response to transmitted/founder virus
contributes to the control of acute viremia in HIV-1 infection. J
Exp Med. 206:1253–1272.
Guindon S, Gascuel O. 2003. A simple, fast and accurate algorithm
to estimate large phylogenies by maximum likelihood. Syst Biol.
52:696–704.
HalpernAL,BrunoWJ.1998.Evolutionarydistancesforprotein-coding
sequences: modeling site-speciﬁc residue frequencies. Mol Biol
Evol. 15:910–917.
Heckerman D, Kadie C, Listgarten J. 2006. Leveraging information
across HLA alleles/supertypes improves epitope prediction.
JC o m p u tB i o l .14:736–746.
Kass RE, Raftery AE. 1995. Bayes factors. J Am StatAssoc. 90:773–795.
Kawashima Y, Pfafferott K, Frater J, et al. (43 co-authors). 2009.
Adaptation of HIV-1 to human leukocyte antigen class I. Nature
458:641–645.
Kosakovsky Pond SL, Frost SDW, Muse SV. 2005. HyPhy: hypothesis
testingusing phylogenies.Bioinformatics 21:676–679.
Kosakovsky Pond SL, Muse SV. 2005. Site-to-site variation of synony-
mous substitutionrates.Mol BiolEvol. 22:2375–2385.
KosakovskyPond SL, Posada D, Gravenor MB, Woelk CH, Frost SDW.
2006. GARD: a genetic algorithm for recombination detection.
Bioinformatics 22:3096–3098.
Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, Lund O,
Nielsen M. 2005. An integrative approach to CTL epitope predic-
tion: a combined algorithm integrating MHC class I binding, TAP
transport efﬁciency, and proteasomal cleavage predictions. Eur J
Immunol. 35:2295–2303.
LeslieA,KavanaghD,HoneyborneI,etal.(27co-authors).2005.Trans-
mission and accumulation of CTL escape variants drive negative
associations between HIV polymorphisms and HLA. JE x pM e d .
201:891–902.
MarshSGE, Parham P, BarberLD. 2000. The HLA factsbook.SanDiego
(CA): Academic Press.
Navis M, Matas DE, Rachinger A, Koning FA, van Swieten P,
Kootstra NA, Schuitemaker H. 2008. Molecular evolution of hu-
man immunodeﬁciency virus type 1 upon transmission between
human leukocyte antigen disparate donor-recipient pairs. PLoS
One.3:e2422.
Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P,
Miedema F, Kootstra N, Schuitemaker H. 2007. Viral replication
capacity as a correlate ofHLA-B57/B5801-associated nonprogres-
sive HIV-1 infection.J Immunol. 179:3133–3143.
Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K,
Buus S, Brunak S, Lund O. 2003. Reliable prediction of T-cell epi-
topesusingneural networkswithnovel sequencerepresentations.
Protein Sci. 12:1007–1017.
Peters HO, Mendoza MG, Capina RE, et al. (13 co-authors). 2008. An
integrativebioinformatic approachforstudyingescapemutations
inhuman immunodeﬁciency virus type1 Gagin thePumwani Sex
Worker Cohort. JV i r o l . 82:1980–1992.
R Development Core Team. 2009. R: a language and environment for
statisticalcomputing. Vienna (Austria): R Foundation for Statisti-
calComputing.
RabinerL.1989. Atutorialonhidden Markovmodels and selectedap-
plications in speech recognition. Proc IEEE. 77:257–286.
RognanD,LauemollerSL,HolmA,BuusS,TschinkeV.1999.Predicting
binding afﬁnities ofprotein ligands from three-dimensional mod-
els: application to peptide binding to class I major histocompati-
bility proteins. J Med Chem. 42:4650–4658.
Rousseau CM, Daniels MG, Carlson JM, et al. (23 co-authors). 2008.
HLA class I-driven evolution of human immunodeﬁciency virus
type 1 subtype C proteome: immune escape and viral load.
JV i r o l . 82:6434–6446.
Schuler MM, Nastke M, Stevanovik´ c S. 2007. SYFPEITHI: database
for searching and T-cell epitope prediction. Methods Mol Biol.
409:75–93.
Siepel A, Haussler D. 2005. Phylogenetic hidden Markov models. In:
Nielsen R,editor. Statisticalmethods in molecular evolution. New
York: Springer. p. 325–351.
Stewart-Jones GBE, Gillespie G, Overton IM, Kaul R, Roche P,
McMichaelAJ,Rowland-JonesS,JonesEY.2005.Structuresofthree
HIV-1 HLA-B*5703-peptide complexes and identiﬁcation of re-
lated HLAspotentially associatedwithlong-termnonprogression.
J Immunol. 175:2459–2468.
Vyas JM, van der Veen AG, Ploegh HL. 2008. The known unknowns
of antigen processing and presentation. Nat Rev Immunol.8 :
607–618.
Yanover C, Hertz T. 2005. Predicting protein-peptide binding afﬁn-
ity by learning peptide-peptide distance functions. In: Miyano S,
Mesirov J, Kasif S, Istrail S, Pevzner P, Waterman M, editors. Re-
search in Computational Molecular Biology, 9th Annual Inter-
national Conference, RECOMB 2005. Cambridge, MA: Springer.
p. 456–471.
YuK, Petrovsky N, SchonbachC, KohJLY, Brusic V. 2002. Methods for
prediction of peptide binding to MHC molecules: a comparative
study.Mol Med. 8:137–148.
Yu XG, Lichterfeld M, Chetty S, et al. (26 co-authors). 2007. Mutually
exclusive T-cell receptor induction and differential susceptibility
tohumanimmunodeﬁciency virus type1mutationalescapeasso-
ciated with atwo-amino-acid difference between HLA classI sub-
types.JV i r o l . 81:1619–1631.
Yusim K, Korber BTM, Brander C, Haynes BF, Koup R, Moore JP,
Walker BD, Watkins DI. 2009. HIV Molecular Immunology 2009.
Los Alamos, NM: Los Alamos National Laboratory, Theoretical
Biology and Biophysics.
Zhao Y, Pinilla C, Valmori D, Martin R, Simon R. 2003. Application of
support vector machines for T-cell epitopes prediction. Bioinfor-
matics 19:1978–1984.
Zwickl DJ. 2006. Genetic algorithm approaches for the phylogenetic
analysis oflargebiologicalsequencedatasetsunder themaximum
likelihoodcriterion[PhDdissertation].[Austin(TX)]:Universityof
Texas at Austin.
1220